PPD’s global pharmacovigilance group gives clients access to a dedicated team, customized to your specific project needs to help you respond to increasing regulatory pressures.
Our experienced group aids in evolving your safety monitoring and safety reporting practices in response to changing regulatory standards, allowing you to evaluate and manage risk over the lifetime of your product.
We employ more than 400 highly skilled medical and safety professionals with first-hand knowledge of regulatory requirements and therapeutic experience, providing safety coverage 24 hours per day, 7 days a week.
PPD keeps you in control of your drug safety and development programs with a robust five-tier quality program to ensure you receive the highest levels of safety services for your study. We give you access to pioneering technology and technical capabilities spanning the full range of pharmacovigilance practices.
We offer a comprehensive and flexible suite of pharmacovigilance and safety monitoring services from early development support through post-approval initiatives.
Early Development Safety and Medical Services
Post-approval Product Support Services
Our advanced pharmacovigilance technologies provide you the ability to view the status of your study in real time and to determine your level of involvement with safety monitoring and data. Through a suite of tools focused solely on collecting and evaluating safety reporting, we deliver the highest levels of quality and compliance for your programs.